Search

everythinglearnresearchcommunity

for

Search:↓

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Finasteride may help some women with hair loss, but better options exist.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Oral spironolactone effectively promotes hair growth in premenopausal women but may cause irregular menstruation.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.